Literature DB >> 12972185

Caveats in the design of MHC class I tetramer/antigen-specific T lymphocytes dissociation assays.

Xiaochi L Wang1, John D Altman.   

Abstract

Relative avidities of antigen-specific T cells for major histocompatibility complex peptide complexes (MHCp) have recently been measured by MHC tetramer dissociation assays, but there is no consensus on the methodologies used for these experiments. While we do not question the conclusions reached in previous studies, in this paper we discuss the caveats that are present in the design of all MHCp tetramer dissociation protocols, and we propose a set of criteria that should be met in the evaluation of appropriate methodologies. We find that it is necessary to use specific reagents to compete with rebinding of the labeled tetramer, but that when either intact anti-MHC antibodies or cold MHC tetramers are used, the dissociation rates are dependent upon the concentrations of the competitor. In contrast, we demonstrate that apparent dissociation rates are independent of the competitor concentration when blocking anti-MHC Fab fragments are used, suggesting that these are the most appropriate reagents to use for tetramer dissociation experiments.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12972185     DOI: 10.1016/s0022-1759(03)00079-6

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  19 in total

Review 1.  TCR signaling requirements for activating T cells and for generating memory.

Authors:  Dietmar Zehn; Carolyn King; Michael J Bevan; Ed Palmer
Journal:  Cell Mol Life Sci       Date:  2012-04-19       Impact factor: 9.261

Review 2.  Quantitative challenges in understanding ligand discrimination by alphabeta T cells.

Authors:  Ofer Feinerman; Ronald N Germain; Grégoire Altan-Bonnet
Journal:  Mol Immunol       Date:  2007-09-06       Impact factor: 4.407

3.  Elevated tumor-associated antigen expression suppresses variant peptide vaccine responses.

Authors:  Charles B Kemmler; Eric T Clambey; Ross M Kedl; Jill E Slansky
Journal:  J Immunol       Date:  2011-09-21       Impact factor: 5.422

4.  2D TCR-pMHC-CD8 kinetics determines T-cell responses in a self-antigen-specific TCR system.

Authors:  Baoyu Liu; Shi Zhong; Karolina Malecek; Laura A Johnson; Steven A Rosenberg; Cheng Zhu; Michelle Krogsgaard
Journal:  Eur J Immunol       Date:  2013-10-20       Impact factor: 5.532

5.  The use of fluorescent target arrays for assessment of T cell responses in vivo.

Authors:  Benjamin J C Quah; Danushka K Wijesundara; Charani Ranasinghe; Christopher R Parish
Journal:  J Vis Exp       Date:  2014-06-19       Impact factor: 1.355

6.  The Antitumor Effects of Vaccine-Activated CD8+ T Cells Associate with Weak TCR Signaling and Induction of Stem-Like Memory T Cells.

Authors:  Sha Wu; Wei Zhu; Yibing Peng; Lan Wang; Yuan Hong; Lei Huang; Dayong Dong; Junping Xie; Todd Merchen; Edward Kruse; Zong Sheng Guo; David Bartlett; Ning Fu; Yukai He
Journal:  Cancer Immunol Res       Date:  2017-08-29       Impact factor: 11.151

7.  Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells.

Authors:  Barbara A Sullivan; Niranjana A Nagarajan; Gerhard Wingender; Jing Wang; Iain Scott; Moriya Tsuji; Richard W Franck; Steven A Porcelli; Dirk M Zajonc; Mitchell Kronenberg
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

8.  Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infection.

Authors:  Mathias Lichterfeld; Xu G Yu; Stanley K Mui; Katie L Williams; Alicja Trocha; Mark A Brockman; Rachel L Allgaier; Michael T Waring; Tomohiko Koibuchi; Mary N Johnston; Daniel Cohen; Todd M Allen; Eric S Rosenberg; Bruce D Walker; Marcus Altfeld
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

9.  High-avidity T cells are preferentially tolerized in the tumor microenvironment.

Authors:  Ziqiang Zhu; Vinod Singh; Stephanie K Watkins; Vincenzo Bronte; Jennifer L Shoe; Lionel Feigenbaum; Arthur A Hurwitz
Journal:  Cancer Res       Date:  2012-11-30       Impact factor: 12.701

10.  Antigen-specific inhibition of high-avidity T cell target lysis by low-avidity T cells via trogocytosis.

Authors:  Brile Chung; Tor B Stuge; John P Murad; Georg Beilhack; Emily Andersen; Brian D Armstrong; Jeffrey S Weber; Peter P Lee
Journal:  Cell Rep       Date:  2014-07-31       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.